lisinopril and hydrochlorothiazide

Generic: lisinopril and hydrochlorothiazide

Labeler: aurobindo pharma limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lisinopril and hydrochlorothiazide
Generic Name lisinopril and hydrochlorothiazide
Labeler aurobindo pharma limited
Dosage Form TABLET
Routes
ORAL
Active Ingredients

hydrochlorothiazide 12.5 mg/1, lisinopril 20 mg/1

Manufacturer
Aurobindo Pharma Limited

Identifiers & Regulatory

Product NDC 65862-044
Product ID 65862-044_5e2383b2-8c0d-450f-b681-74bfb12942a7
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077606
Listing Expiration 2026-12-31
Marketing Start 2006-03-14

Pharmacologic Class

Established (EPC)
thiazide diuretic [epc]
Chemical Structure
thiazides [cs]
Physiologic Effect
increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65862044
Hyphenated Format 65862-044

Supplemental Identifiers

RxCUI
197885 197886 197887
UNII
0J48LPH2TH E7199S1YWR
NUI
N0000175359 N0000175419 M0471776

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lisinopril and hydrochlorothiazide (source: ndc)
Generic Name lisinopril and hydrochlorothiazide (source: ndc)
Application Number ANDA077606 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 12.5 mg/1
  • 20 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (65862-044-00)
  • 100 TABLET in 1 BOTTLE (65862-044-01)
  • 500 TABLET in 1 BOTTLE (65862-044-05)
  • 30 TABLET in 1 BOTTLE (65862-044-30)
  • 1000 TABLET in 1 BOTTLE (65862-044-99)
source: ndc

Packages (5)

Ingredients (2)

hydrochlorothiazide (12.5 mg/1) lisinopril (20 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5e2383b2-8c0d-450f-b681-74bfb12942a7", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "unii": ["0J48LPH2TH", "E7199S1YWR"], "rxcui": ["197885", "197886", "197887"], "spl_set_id": ["d7214539-6c3d-466a-a474-6fde096fa182"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (65862-044-00)", "package_ndc": "65862-044-00", "marketing_start_date": "20060314"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (65862-044-01)", "package_ndc": "65862-044-01", "marketing_start_date": "20060314"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (65862-044-05)", "package_ndc": "65862-044-05", "marketing_start_date": "20060314"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (65862-044-30)", "package_ndc": "65862-044-30", "marketing_start_date": "20060314"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (65862-044-99)", "package_ndc": "65862-044-99", "marketing_start_date": "20060314"}], "brand_name": "Lisinopril and Hydrochlorothiazide", "product_id": "65862-044_5e2383b2-8c0d-450f-b681-74bfb12942a7", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "65862-044", "generic_name": "Lisinopril and Hydrochlorothiazide", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisinopril and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "LISINOPRIL", "strength": "20 mg/1"}], "application_number": "ANDA077606", "marketing_category": "ANDA", "marketing_start_date": "20060314", "listing_expiration_date": "20261231"}